Cargando…
Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer
Novel agents are required to increase the radiosensitivity of cancer and improve the outcome of radiotherapy. Thioredoxin (Trx) and thioredoxin reductase (TrxR) reduce the oxidized cysteine thiols in several proteins, which regulate cellular redox, survival, proliferation, DNA synthesis, transcripti...
Autores principales: | Patwardhan, Raghavendra S., Sharma, Deepak, Sandur, Santosh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790659/ https://www.ncbi.nlm.nih.gov/pubmed/35078017 http://dx.doi.org/10.1016/j.tranon.2022.101341 |
Ejemplares similares
-
Thioredoxin Reductase Activity Predicts Gold Nanoparticle Radiosensitization Effect
por: Penninckx, Sébastien, et al.
Publicado: (2019) -
Involvement of ERK-Nrf-2 Signaling in Ionizing Radiation Induced Cell Death in Normal and Tumor Cells
por: Patwardhan, Raghavendra S., et al.
Publicado: (2013) -
Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression
por: Selenius, Markus, et al.
Publicado: (2012) -
Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
por: Wang, Hui, et al.
Publicado: (2017) -
Thioredoxin Reductase and its Inhibitors
por: Saccoccia, Fulvio, et al.
Publicado: (2014)